论文部分内容阅读
目的了解医院DHPs-CCB使用情况,为临床高血压病的合理治疗提供参考和建议。方法采用回顾性分析方法,收集医院2011-2013年口服抗高血压药物的使用信息,统计各类抗高血压药物的使用金额、DHPsCCB的DDDs和DDDc等进行分析。结果 2011-2013年DHPs-CCB的使用金额占所有抗高血压药物使用金额的38.10%、36.62%和34.49%。左旋氨氯地平始终占据使用金额首位。各种DHPs-CCB用药金额和用药人数同步性良好。结论医院DHPs-CCB的使用符合亚洲医学临床治疗高血压的发展方向。
Objective To understand the use of DHPs-CCB in hospitals and provide references and recommendations for the rational treatment of clinical hypertension. Methods The retrospective analysis method was used to collect the usage information of oral antihypertensive drugs in hospitals from 2011 to 2013, and the usage amounts of various antihypertensive drugs, DDDs and DDDc of DHPsCCB were analyzed. Results The amount of DHPs-CCB used in 2011-2013 accounted for 38.10%, 36.62% and 34.49% of the total amount of antihypertensive drugs used. Levamlodipine always occupy the top of the amount used. Various DHPs-CCB medication amount and the number of patients with good synchronization. Conclusion The use of DHPs-CCB in hospital is in line with the development of hypertension in clinical medicine in Asia.